Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

CoapTech

Explore full profile

Early-stage medical device company aiming to improve medical care delivery for patients young and old around the world

Baltimore, United StatesFounded 2016Biotech & Life Sciences
Valuation $25–50M Last recorded · 2025
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for CoapTech and the history behind them.

About CoapTech

CoapTech, founded in 2016 by Dr. Steven Tropello and Howard Carolan, is a medical device company that has developed a platform for minimally invasive, ultrasound-guided procedures in hollow organs. The company is headquartered in Baltimore, Maryland.

Dr. Tropello, a physician, invented the company's core technology, the Point-of-care Ultrasound Magnet Aligned (PUMA) System. This system utilizes magnetic coaptation and ultrasound guidance to allow for safer and more efficient bedside procedures, which have traditionally been performed in operating rooms.

The company's first product, the PUMA-G System, is designed for gastrostomy tube placement. This procedure is essential for patients who are unable to eat or drink by mouth. By enabling this procedure to be done at the bedside, CoapTech aims to reduce healthcare costs, improve patient safety and experience, and increase access to care.

CoapTech operates on a business model of manufacturing and selling these medical devices to healthcare facilities. The company has progressed to a Series B funding stage, indicating investor confidence in its technology and market potential.

Source: Dealroom company data

At a glance

Founded
2016
Headquarters
Baltimore, United States
Sector
Biotech & Life Sciences

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed4 investors entered at this stage

  • Dingman Center Angels
  • National Institutes of Health
  • TEDCO
  • National Institute of Diabetes and Digestive and Kidney Diseases

Series A7 investors entered at this stage

  • Hunniwell Lake Ventures
  • Good Growth Capital
  • Abell Foundation
  • Maryland Momentum Fund
  • Ecphoracapital
  • NuFund Venture Group
  • University of Maryland, Baltimore (UMB)
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about CoapTech on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CoapTech on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.